Known as Body Protection Compound with broad research interests Commonly used within studies of recovery and regeneration Interesting for research on muscles, tendons and joints Unique link to the digestive system Suitable for various experimental applications within life sciences The combination of versatility and intense research interest has made BPC-157 a fixture within modern peptide research
Unlike growth hormone or anabolic steroids, it does not drive sodium retention or fluid accumulation in clinically meaningful amounts
For recovery enhancement, performance optimisation, or longevity goals in healthy people, until a randomised, placebo-controlled trial in a defined population with an objective primary endpoint and pharmacovigilance over a clinically meaningful duration produces data we do not currently have, we just don't have good evidence of benefit, let alone safety
The world anti-doping agency (WADA), an international agency in charge of governing the use of drugs in sports, banned the use of BPC-157 by athletes in 2022 [11]
however, the number decreased from 80.8% in 2020 to 58.2% in 2023